Published January 1, 2020 | Version v1
Journal article Open

A clinical score to guide in decision making for monogenic type I IFNopathies

  • 1. Hacettepe Univ, Dept Pediat, Div Rheumatol, Fac Med, Ankara, Turkey
  • 2. Hacettepe Univ, Dept Biol, Mol Biol Sect, Fac Sci, Ankara, Turkey
  • 3. NIAID, Translat Autoinflammatory Dis Sect TADS, Lab Clin Immunol & Microbiol LCIM, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
  • 4. Hacettepe Univ, Dept Pediat, Div Neurol, Fac Med, Ankara, Turkey
  • 5. Umraniye Res & Training Hosp, Dept Pediat, Div Rheumatol, Istanbul, Turkey
  • 6. Hacettepe Univ, Dept Pediat, Div Immunol, Fac Med, Ankara, Turkey

Description

OBJECTIVE: To develop a set of clinical criteria that identifies patients with a potential autoinflammatory IFNopathy.

Files

bib-29b1d826-c1e1-4c88-9a1f-084b58dcf975.txt

Files (279 Bytes)

Name Size Download all
md5:5d53044c5df02aba17cf9a7050b5093e
279 Bytes Preview Download